Physician profile
Jehad S Saleh
NPI 1891272076
$8,887.91
in general payments reported to CMS, 2019-2025
20 companies · $4,795 in 2025
The $4,795 reported for 2025 was more than what 99% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $743 · 2022: $923 · 2023: $563 · 2024: $1,863 · 2025: $4,795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,773 · Travel and Lodging: $3,431 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,773.46 |
| Travel and Lodging | $3,430.56 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,515.20 | 2024-2025 | Linq II, Affera Mapping System, Omniasecure Mri Surescan |
| Boston Scientific Corporation | $1,780.58 | 2021-2025 | Watchman Flx, Momentum El Icd Vr, Accolade Sr |
| Amgen INC. | $625.90 | 2021-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals Lp | $340.96 | 2021-2025 | Farxiga |
| Novo Nordisk INC | $321.10 | 2022-2024 | Ozempic |
| Pfizer INC. | $202.84 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.61 | 2022 | |
| United Therapeutics Corporation | $156.19 | 2021-2024 | Tyvaso |
| Esperion Therapeutics, INC. | $125.01 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $117.36 | 2021 | |
| Abiomed | $106.44 | 2023 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.03 | 2022-2025 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $79.14 | 2021 | |
| Kestra Medical Technology Services, INC. | $63.33 | 2022-2024 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $61.67 | 2022-2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $48.08 | 2024 | Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $28.33 | 2022 | |
| Sanofi-Aventis U.S. LLC | $21.29 | 2023 | |
| Vapotherm INC | $20.51 | 2023 | Vapotherm |
| Merck Sharp & Dohme LLC | $16.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jehad Saleh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.